i-Base home
Search Menu
  • Home
  • HTB
  • 2025
  • January

January 2025

Contents

Editorial

  • Looking back through 2024 and forward to 2025…
  • i-Base appeal: Q&A services and the website in 2025

Special reports

  • Almost 1 in 5 people in Switzerland disconnected from HIV care over 10 years: only half reconnected and with advanced infection
  • ART pipeline 2025: exciting dual long-acting combinations and the challenge of generic dolutegravir

Antiretrovirals

  • EU license for injectable cabotegravir/rilpivirine injections expanded to include adolescents >12 years old
  • Transient impact of lenacapavir against MDR HIV-2 without other active ART
  • Lenacapavir submitted to the US FDA with an indication for HIV PrEP

Treatment access

  • US issues temporary waiver to re-enable PEPFAR
  • IAS statement: PEPFAR freeze threatens millions of lives
  • Trump bans travel for US government scientists, presentations restricted, language bans, documents disappearing

Pregnancy

  • BHIVA pregnancy guidelines online for comment: deadline 25 January

mpox

  • Detailed results from PALM007 study: no clinical impact of tecovirimat against mpox clade 1
  • Tecovirimat news continues: Japan approval includes mpox indication
  • HTB RSS

Early access

  • Vaccination effectively limits mpox progression: lower efficacy in people living with HIV 27 May 2025
  • US update guidelines for statin use in people living with HIV 26 May 2025
  • HIV activists in the US call for action and Zachie Achmet brings South African perspective 26 May 2025
  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook